health

Vaccine makers are designing follow-up shots, based on new mutations, to keep the disease at bay

Companies are scrambling to obtain supplies for hundreds of millions of doses of a type of vaccine that has never been made at this scale before

The country’s leading expert on infectious diseases shares his thoughts on resolving the current public health crisis and preparing for the next

Even with vaccines on the way, treatments are needed to prevent the disease from getting worse—and to be ready for COVID-25, COVID-37, and so on

The data are preliminary, however, and it is not yet clear whether the vaccine protects against severe disease

A vaccine made by Pfizer could seek emergency approval by the third week of November, but it likely won’t be available to the public until mid- to late 2021